Opus Genetics Announces Financial Results for Full Year 2024
Provides update on the Company’s transformation and promising portfolio of innovative gene therapy treatments for inherited retinal ...
Eyenovia, Inc. (NASDAQ:EYEN) Sees Large Drop in Short Interest
Eyenovia, Inc. (NASDAQ:EYEN – Get Free Report) saw a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 138,200 shares, a drop of 41.4% from the ...